Published in Diabetologia on December 01, 1992
Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A (1999) 1.91
Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. Diabetologia (2007) 1.12
Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J Clin Invest (1998) 1.08
The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes (2012) 0.94
Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J (2002) 0.92
Prognostic value of endothelial dysfunction in type 1 diabetes mellitus. World J Diabetes (2014) 0.89
Intracellular signalling by C-peptide. Exp Diabetes Res (2008) 0.89
Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes. Exp Diabetes Res (2008) 0.89
Does C-peptide have a physiological role? Diabetologia (1994) 0.88
C-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC study. Diabetes Care (2012) 0.88
Role of C-Peptide in the regulation of microvascular blood flow. Exp Diabetes Res (2008) 0.86
The beneficial effects of C-Peptide on diabetic polyneuropathy. Rev Diabet Stud (2009) 0.84
C-Peptide effects on renal physiology and diabetes. Exp Diabetes Res (2008) 0.80
Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications? Vasc Health Risk Manag (2008) 0.79
C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients. Exp Diabetes Res (2008) 0.79
Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action. Biologics (2008) 0.78
The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat. Exp Diabetes Res (2008) 0.78
Sequence requirements for proinsulin processing at the B-chain/C-peptide junction. Biochem J (1995) 0.77
Molecular effects of C-Peptide in microvascular blood flow regulation. Rev Diabet Stud (2009) 0.77
Influence of C-peptide on glucose utilisation. Exp Diabetes Res (2008) 0.76
Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus. World J Diabetes (2015) 0.75
C-peptide has no effect on forearm blood flow during local hyperinsulinaemia in healthy humans. Br J Clin Pharmacol (2003) 0.75
Will C-peptide substitution make a difference in combating complications in insulin-deficient diabetes? Rev Diabet Stud (2004) 0.75
ω-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity. J Clin Invest (2017) 0.75
An update on the potential role of C-peptide in diabetes and osteoporosis. Endocrine (2017) 0.75
The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes (1981) 7.28
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest (1985) 4.38
Amino acid metabolism during prolonged starvation. J Clin Invest (1969) 4.06
Liver and kidney metabolism during prolonged starvation. J Clin Invest (1969) 3.47
Leg blood flow during exercise in man. Clin Sci (1971) 2.97
Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes (1983) 2.45
Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids. J Clin Invest (1974) 2.40
Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest (1996) 2.33
Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man. J Clin Invest (1971) 2.29
Amino acid metabolism in exercising man. J Clin Invest (1971) 2.29
Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest (1976) 2.27
Glucose metabolism during leg exercise in man. J Clin Invest (1971) 2.27
Nonproductive exchanges: the use of isotopes gone astray. Metabolism (1992) 2.12
Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. J Clin Invest (1972) 2.11
Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci U S A (1978) 2.08
Increased 24-hour energy expenditure in cigarette smokers. N Engl J Med (1986) 2.01
Insulin resistance in uremia. J Clin Invest (1981) 1.98
Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res (1998) 1.92
Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A (1999) 1.91
The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes (1985) 1.88
Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state. J Clin Invest (1995) 1.76
Splanchnic glucose and amino acid metabolism in obesity. J Clin Invest (1974) 1.73
Fuel homeostasis in exercise. N Engl J Med (1975) 1.73
Influence of oral glucose ingestion on splanchnic glucose and gluconeogenic substrate metabolism in man. Diabetes (1975) 1.68
Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest (1972) 1.63
Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med (2000) 1.63
Evidence of inter-organ amino-acid transport by blood cells in humans. Proc Natl Acad Sci U S A (1973) 1.60
Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest (1981) 1.59
Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes (1978) 1.58
Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest (1995) 1.58
Simulation and evaluation of nicotine intake during passive smoking: cotinine measurements in body fluids of nonsmokers given intravenous infusions of nicotine. Clin Pharmacol Ther (1990) 1.52
The effect of local anaesthetics on the central circulation and respiration in man and dog. Acta Anaesthesiol Scand (1968) 1.50
Infusion of ornithine-alpha-ketoglutarate in healthy subjects: effects on protein metabolism. Clin Nutr (1985) 1.47
The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia (1992) 1.47
Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus. J Clin Invest (1975) 1.46
Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab (1994) 1.44
Influence of age on the local circulatory adaptation to leg exercise. Scand J Clin Lab Invest (1974) 1.43
Noninvasive tracing of Krebs cycle metabolism in liver. J Biol Chem (1991) 1.43
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol (1983) 1.43
Hypoglycemia during prolonged exercise in normal men. N Engl J Med (1982) 1.42
Metabolism of [2-14C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis. J Biol Chem (1991) 1.38
Proinsulin C-peptide--a consensus statement. Int J Exp Diabetes Res (2001) 1.38
Beta-adrenergic blockade does not influence the thermogenic response to a mixed meal in man. Clin Physiol (1989) 1.38
Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin. Proc Natl Acad Sci U S A (1977) 1.35
Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet (1976) 1.33
Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol (1980) 1.32
Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab (1993) 1.29
Human forearm muscle metabolism during exercise. II. Uptake, release and oxidation of individual FFA and glycerol. Scand J Clin Lab Invest (1968) 1.28
Substance P: a pioneer amongst neuropeptides. J Intern Med (2001) 1.28
Substrate utilization by the inactive leg during one-leg or arm exercise. J Appl Physiol (1975) 1.23
Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes (1999) 1.22
Cerebral effects of nicotine during cognition in smokers and non-smokers. Psychopharmacology (Berl) (1998) 1.20
Determination of leg blood flow during exercise in man: an indicator-dilution technique based on femoral venous dye infusion. Clin Sci Mol Med (1973) 1.17
Quantitative aspects of blood flow and oxygen uptake in the human forearm during rhythmic exercise. Acta Physiol Scand Suppl (1966) 1.17
Augmented thermic effect of amino acids under general anaesthesia: a mechanism useful for prevention of anaesthesia-induced hypothermia. Clin Sci (Lond) (1994) 1.15
Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans. J Clin Invest (1977) 1.13
Circulatory responses to arm exercise with different arm positions. J Appl Physiol (1968) 1.13
Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus. Diabetes (1976) 1.13
Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men. Atherosclerosis (1997) 1.12
Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise. J Clin Invest (1984) 1.12
Renal substrate exchange in human diabetes mellitus. Diabetes (1975) 1.11
Physiological variation of blood lymphocyte reactivity: T-cell subsets, immunoglobulin production, and mixed-lymphocyte reactivity. Clin Immunol Immunopathol (1983) 1.10
C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y. Diabetologia (1996) 1.10
Effects of accidental intramuscular injection on insulin absorption in IDDM. Diabetes Care (1988) 1.09
Physical exercise and fuel homeostasis in diabetes mellitus. Diabetologia (1978) 1.09
Influence of beta-adrenergic blockade on glucose-induced thermogenesis in man. J Clin Invest (1983) 1.08
Plasma glucagon levels in exercising man. N Engl J Med (1972) 1.08
Human forearm muscle metabolism during exercise. V. Quantitative aspects of glucose uptake and lactate production during prolonged exercise. Scand J Clin Lab Invest (1970) 1.08
Differentiated sympathetic activation during mental stress evoked by the Stroop test. Acta Physiol Scand Suppl (1984) 1.08
Leg glucose uptake during maximal dynamic exercise in humans. Am J Physiol (1986) 1.08
Influence of leucine on arterial concentrations and regional exchange of amino acids in healthy subjects. Clin Sci (Lond) (1980) 1.07
Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia (1998) 1.07
C-peptide improves autonomic nerve function in IDDM patients. Diabetologia (1996) 1.06
Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int J Obes Relat Metab Disord (1996) 1.06
Human forearm muscle metabolism during exercise. 3. Uptake, release and oxidation of beta-hydroxybutyrate and observations on the beta-hydroxybutyrate/acetoacetate ratio. Scand J Clin Lab Invest (1968) 1.06
Thermic effect of glucose in man. Obligatory and facultative thermogenesis. J Clin Invest (1984) 1.05
Quantifying gluconeogenesis during fasting. Am J Physiol (1997) 1.04
C-peptide stimulates Na+, K+-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol Life Sci (2004) 1.04
Protein turnover and amino acid metabolism in the regulation of gluconeogenesis. Fed Proc (1974) 1.04
Muscle metabolism during exercise in hemiparetic patients. Clin Sci Mol Med (1977) 1.04
Splanchnic glucose and muscle glycogen metabolism after glucose feeding during postexercise recovery. Am J Physiol (1978) 1.03
Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man. J Clin Invest (1976) 1.03
Long-term use of smokeless tobacco and physical performance in middle-aged men. Eur J Clin Invest (1997) 1.02
Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell Mol Life Sci (2006) 1.02
Glutamine and glutamate metabolism in normal and diabetic subjects. Diabetes (1973) 1.02
The influence of sympathetic activity and histamine on the blood-tissue exchange of solutes in canine adipose tissue. Acta Physiol Scand (1974) 1.02
Effects of pancreas transplantation on metabolic and hormonal profiles in IDDM patients. Diabetes (1989) 1.02
The contrasting responses of splanchnic and renal glucose output to gluconeogenic substrates and to hypoglucagonemia in 60-h-fasted humans. Diabetes (1980) 1.02
Renal oxygen consumption, thermogenesis, and amino acid utilization during i.v. infusion of amino acids in man. Am J Physiol (1994) 1.01
Splanchnic and muscle metabolism during exercise in NIDDM patients. Am J Physiol (1995) 1.01
A limitation in the use of mass isotopomer distributions to measure gluconeogenesis in fasting humans. Am J Physiol (1995) 1.00
Absorption of rapid-acting insulin in obese and nonobese NIDDM patients. Diabetes Care (1995) 1.00
Human forearm muscle metabolism during exercise. VI. Substrate utilization in prolonged fasting. Scand J Clin Lab Invest (1971) 1.00
Glucose and amino acid metabolism during recovery after exercise. J Appl Physiol (1973) 1.00
Splanchnic and renal exchange of infused fructose in insulin-deficient type 1 diabetic patients and healthy controls. J Clin Invest (1989) 0.99
Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. Metabolism (1994) 0.98
Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load. J Clin Invest (1987) 0.98
Human forearm muscle metabolism during exercise. VII. FFA uptake and oxidation at different work intensities. Scand J Clin Lab Invest (1972) 0.97